Effect of etanercept on cytokines and 13, 14-dihydro-15-keto-prostaglandin F2 alpha concentrations during endotoxemia

dc.contributor.authorEr, A.
dc.contributor.authorDik, B.
dc.contributor.authorAltan, F.
dc.contributor.authorCetin, G.
dc.contributor.authorUney, K.
dc.contributor.authorElmas, M.
dc.contributor.authorYazar, E.
dc.date.accessioned2020-03-26T18:24:59Z
dc.date.available2020-03-26T18:24:59Z
dc.date.issued2012
dc.departmentSelçuk Üniversitesien_US
dc.description.abstract[Abstract not Available]en_US
dc.identifier.endpage138en_US
dc.identifier.issn0140-7783en_US
dc.identifier.startpage137en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/27940
dc.identifier.volume35en_US
dc.identifier.wosWOS:000310251900215en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWILEY-BLACKWELLen_US
dc.relation.ispartofJOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICSen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleEffect of etanercept on cytokines and 13, 14-dihydro-15-keto-prostaglandin F2 alpha concentrations during endotoxemiaen_US
dc.typeConference Objecten_US

Dosyalar